* Biotricity Inc BTCY.OQ BTCY.O is expected to report
results on February 9 (estimated).
* The Redwood City California-based company is expected to
report
revenue of $2.408 million, according to the mean estimate from 2
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Biotricity Inc is
for a
loss of 13 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Biotricity
Inc is
$7, about 53.7% above its last closing price of $3.24.
This summary was machine generated February 8 at 03:03 GMT. All
figures in US dollars unless otherwise stated